NDC 51311-034 - AYRADIA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51311-034
- Package NDCs from labels
- 51311-034-30, 51311-034-10
- Manufacturer
- Virbac AH Inc
- Effective date
- 2023-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AYRADIA - Virbac AH Inc | Virbac AH Inc | 2023-10-26 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51311-034-10 | AYRADIA | 100 mL in 1 BOTTLE | SOLUTION | 100 | 1 | |
| 51311-034-10 | AYRADIA | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 51311-034-30 | AYRADIA | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 51311-034-30 | AYRADIA | 30 mL in 1 BOTTLE | SOLUTION | 30 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole Vaginal Gel | METRONIDAZOLE VAGINAL GEL, 1.3 % | Encube Ethicals, Inc. | 585d2553-e19f-4227-82db-e4c2034863bf | 2025-09-15 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 356579f3-a9ed-49cf-bc0d-47b58a58cf85 | 2025-09-12 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE TOPICAL | Encube Ethicals, Inc. | 05707735-e676-412a-9a77-ebd003afb16c | 2025-09-12 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Sagent Pharmaceuticals | d46870f5-e2b1-46bd-8413-4a0a8bcf3175 | 2025-08-14 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Amneal Pharmaceuticals Private Limited | 843447a5-525c-48ea-860a-230db549fecb | 2025-07-17 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Aurobindo Pharma Limited | 0b6f6fbd-0292-4c48-a4ae-c24b5f0c8f74 | 2025-07-11 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Baxter Healthcare Corporation | d2112f37-5080-4a19-bcc3-6386b49abe1d | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Baxter Healthcare Corporation | 9d762edb-12ac-429d-b1f0-7af5d3b909d4 | 2025-06-12 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Golden State Medical Supply, Inc. | a6ceb47b-d0b0-d377-e053-2995a90a463e | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Golden State Medical Supply, Inc. | a6ce16b7-25c5-48aa-e053-2a95a90aa947 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | b1d13c9f-cf8e-4646-e053-2a95a90a4a35 | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| LIKMEZ | METRONIDAZOLE ORAL | Saptalis Pharmaceuticals, LLC | e20c14eb-5361-4a93-ab46-a7bd9aeb9b98 | 2025-04-18 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Redpharm Drug, inc. | f426cddc-8b70-c0a7-e053-2995a90a74e0 | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | AMICI PHARMA INC | 9f1fec88-097f-42b9-a36f-214648d7eebb | 2025-04-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | AMICI PHARMA INC | 4920fcf7-5ceb-46e9-82e0-dc508900bb91 | 2025-04-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | e43b880b-ce69-4f56-9c1c-9c7ca23bba84 | 2025-03-18 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Inc. | f9b4c86c-932b-4b43-ab1a-6d9e07958044 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals, Inc. | 4ab90d8e-c21f-65ac-e054-00144ff8d46c | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| SEACALL Mouthwash | MOUTHWASH | Guangdong Quadrant Ecological Technology Co., Ltd. | 2c1a7eed-6a7c-eeb2-e063-6394a90aafcc | 2025-01-19 | Warnings | 140QMO216E |
| metronidazole vaginal | METRONIDAZOLE | Saptalis Pharmaceuticals LLC | 08abacec-3b6a-43e7-bfaa-2041d87a26c7 | 2025-01-14 | Warnings, Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.